Company Spotlight

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile


Contract Service Directory


Tulex Pharmaceuticals Inc.





Company Headquarters

5 Cedar Brook Drive
Cranbury, NJ 08512
United States

Contract Service Directory

    Related Content

    • Drug Delivery | Formulation Development | Industry News
      Rutgers, Catalent to Research Pediatric Formulation/Drug Delivery

      Rutgers, Catalent to Research Pediatric Formulation/Drug Delivery

      Aims to identify and address the challenges associated with pediatric formulation and drug delivery
      01.05.18

    • Serialization: Optimizing Planning and Implementation

      Serialization: Optimizing Planning and Implementation

      How an Outsourcing Partner Can Deliver Efficient Serialization Solutions

    • Industry News | Promotions & Moves
      New SVP of Product Development Joins Vyome

      New SVP of Product Development Joins Vyome

      Dr. Chavdarian brings over 30 years of experience across multiple areas in the industry
      11.13.17


    • Industry News
      Almirall Signs Off On New Manufacturing Execution System

      Almirall Signs Off On New Manufacturing Execution System

      Werum’s PAS-X will be rolled out to cover the entire manufacturing process
      11.07.17


    • Analytical Services | Industry News
      AMRI Offers Stand-Alone Impurity Services

      AMRI Offers Stand-Alone Impurity Services

      New regulatory requirements drive increase in analytical testing services
      10.13.17


    • cGMP Manufacture | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Tulex Completes NJ Development and Manufacturing Facility

      Tulex Completes NJ Development and Manufacturing Facility

      cGMP facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dose
      10.13.17

    • Regulatory Affairs
      ANDA Refuse-to-Receive Pitfalls and How to Avoid Them

      ANDA Refuse-to-Receive Pitfalls and How to Avoid Them

      A review of FDA expectations
      Jean Poulos, Lachman Consultants 10.11.17

    • Regulatory Affairs
      FDARA and Beyond

      FDARA and Beyond

      In a few short years, PBOA establishes itself as a key industry resource
      Gil Roth, Pharma & Biopharma Outsourcing Association 09.06.17


    • cGMP Manufacture | Industry News | Regulatory Affairs
      FDA Releases FY 2018 GDUFA Rates

      FDA Releases FY 2018 GDUFA Rates

      The FY 2018 fee represents a significant drop from FY17's FDF fee of $258,646
      08.28.17

    • Breaking News | Industry News | Laboratory Testing
      BASF Opens South Asia Pharma Lab

      BASF Opens South Asia Pharma Lab

      Upgraded facility in Mumbai focuses on technical innovation and new application scouting
      08.16.17

    • Industry News | Logistics | Serialization
      Adents Obtains Gateway Provider Certification

      Adents Obtains Gateway Provider Certification

      Passes series of tests with the EMVO for connection to the European Hub for serialization offering
      08.14.17


    • 12	Teva

      12 Teva

      ...
      07.24.17

    • Breaking News | Capsules | Collaborations & Alliances | Drug Development | Industry News
      Glenmark Partners With Cyndea Pharma

      Glenmark Partners With Cyndea Pharma

      Together will develop, license, manufacture and supply for commercialization generic soft-gelatin capsule drug products
      07.19.17